Increased pertechnegas lung clearance in interstitial lung disease

Clinical Nuclear Medicine

Volumn 24, Issue 2, 1999, Pages 105-108

  Mouratidis, Bill ^a   Lising, Joe ^a   Nogrady, Stephen ^a   Hurwitz, Mark ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

Fibrosing Alveolitis; Interstitial Lung Disease; Pertechnegas

Indexed keywords

PENTETATE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; LUNG CLEARANCE; MALE; THORAX RADIOGRAPHY;

ADULT; AGED; BLOOD-AIR BARRIER; FEMALE; GRAPHITE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PERMEABILITY; PULMONARY FIBROSIS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SODIUM PERTECHNETATE TC 99M;

EID: 0032891338     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199902000-00006     Document Type: Article

References (20)

1. Rinderknecht J, Shapiro L, Krauthammer M, et al: Accelerated clearance of small solutes from the lungs in interstitial lung disease. Am Rev Resp Dis 121:105, 1990.
2. Schmekel B. Wollmer P, Venge P, et al: Transfer of Tc-99m DTPA and bronchoalveolar lavage findings in patients with asymptomatic extrinsic allergic alveolitis. Thorax 45:525, 1990.
3. Fanti S, De Fabritiis A, Aloisi D, et al: Early pulmonary involvement in systemic sclerosis assessed by technetium-Tc-99m DTPA clearance rate. J Nucl Med 35:1933, 1994.
4. Rosso J, Guillon JM, Parrot A, et al: Technetium-99m-DTPA aerosol and gallium-67 scanning in pulmonary complications of human immunodeficiency virus infection. J Nucl Med 33:81, 1992.
5. Susskind H, Rom WN: Lung inflammation in coal miners assessed by uptake of Ga-67 citrate and clearance of inhaled 99m Tc-labeled diethylenetriamine pentaacetate aerosol. Am Rev Respir Dis 146:47, 1992.
6. Susskind H, Weber DA, Lau YH, et al: Impaired permeability in radiation-induced lung injury detected by technetium-99m-DTPA. J Nucl Med 38:966, 1997.
7. Huchon GJ, Russell JA, Barritault LG, et al: Chronic air-flow limitation does not increase respiratory epithelial permeability assessed by aerosolised solute but smoking does. Am Rev Respir Dis 130:457, 1984.
8. Monaghan P, Murray IPC, Mackey DWJ, et al: An improved radionuclide technique for the detection of altered pulmonary permeability. J Nucl Med 31:1945, 1991.
9. Burch WM, Sullivan PJ, McLaren C: Technegas - A new ventilation agent for lung scanning. Nucl Med Commun 7:865, 1986.
10. Sullivan PJ, Burke WM, Burch WM, et al. A clinical comparison of technegas and Xenon-133 in 50 patients with suspected pulmonary embolism. Chest 94:300, 1988.
11. Hilson AJW, Pavia D, Diamond PD, et al: An ultrafine Tc-99m aerosol (technegas) for lung ventilation scintigraphy - A comparison with Kr-81m. J Nucl Med 30:744, 1989.
12. Lemb M, Oei TH, Eifert H, et al: Technegas: A study of particle structure, size and distribution. Eur J Nuc Med 20:576, 1993.
13. Fraser RG, Pare JA, Pare PD, et al: Pulmonary disease of unknown origin. Diagnosis of Diseases of the Chest, 3rd ed. Philadelphia: WB Saunders, 1991, p 2633
14. Muller NL, Miller RR, Webb WR, et al: Fibrosing alveolitis: CT-pathological correlation. Radiology 160:585, 1986.
15. Bois RM: The predictive value of appearances of thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 148:1076, 1993.
16. Remy-Jardin M, Giraud F, Remy J, et al: Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: Pathologic-CT correlation. Radiology 189: 693, 1993.
17. Pande JN: Interrelationship between lung volume, expiratory flow and lung transfer factor in fibrosing alveolitis. Thorax 36:858, 1981.
18. Caner B, Ugur O, Bayraktar M, et al: Impaired lung epithelial permeability in diabetics detected by technetium-99m DTPA aerosol scintigraphy. J Nucl Med 35:204, 1994.
19. Wells AU, Hansell DM, Harrison NK, et al: Clearance of inhaled Tc-99m DTPA predicts clinical course of fibrosing alveolitis. Eur Resp J 6:797, 1993.
20. Turner-Warwick M, Burrows B, Johnson A: Cryptogenic fibrosing alveolitis: Response to corticosteroid treatment and its effect on survival. Thorax 35:593, 1980. TM-1 Tetley Technologies (Sydney, Australia).